The Scotts Miracle
SMG
49.40
-1.12
-2.22%
The Scotts Miracle
US · SMG
#2541 by market cap
Listed 1970
49.40
-1.12
-2.22%
Live - 5344 symbols - heartbeat 534s ago
· 2026-10-07 20:02
After-hours
49.40
0.00%
- Market cap
- 2.88B
- P/E (TTM)i
- 40.49
- P/Bi
- -13.78
- EPSi
- 2.47
- Div yieldi
- 5.34%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on SMG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.55, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.93% YoY
Margins
- Gross margin
- 30.59%
- Operating margin
- 12.36%
- Net margin
- 4.25%
Key ratios & quality
- Enterprise valuei
- 5.02B
- Altman Z-Scorei
- 2.55
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.66B | 3.16B | 4.13B | 4.93B | 3.92B | 3.55B | 3.55B | 3.41B |
| Gross profit | 864.60M | 1.02B | 1.35B | 1.47B | 872.90M | 657.30M | 850.50M | 1.04B |
| Selling & admin expenses | 468.70M | 528.80M | 686.60M | 669.00M | 536.70M | 493.00M | 510.50M | 556.90M |
| Research & development | 42.50M | 39.60M | 39.70M | 45.40M | 45.30M | 35.70M | 34.60M | 34.80M |
| Operating profit | 324.50M | 418.30M | 586.00M | 727.30M | 259.10M | 106.10M | 271.60M | 422.00M |
| Pretax profit | 115.70M | 581.60M | 510.60M | 677.10M | -558.10M | -453.30M | -23.60M | 221.70M |
| Tax | -11.90M | 144.90M | 123.70M | 159.80M | -120.60M | -73.20M | 11.30M | 76.50M |
| Net profit | 63.70M | 460.20M | 388.60M | 513.40M | -437.50M | -380.10M | -34.90M | 145.20M |
| Basic EPS | 1 | 8 | 7 | 9 | -8 | -7 | -1 | 3 |
| Diluted EPS | 1.12 | 8.18 | 6.81 | 8.96 | -7.88 | -6.79 | -0.61 | 2.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.39B | 1.16B | 497.40M | 354.40M | 1.46B | 1.17B |
| Gross profit | 542.10M | 372.70M | 40.90M | 88.70M | 610.50M | 365.90M |
| Selling & admin expenses | 169.20M | 136.20M | 145.10M | 95.50M | 191.20M | 136.90M |
| Research & development | 7.90M | 7.90M | 12.40M | 9.80M | 7.30M | 8.00M |
| Operating profit | 360.10M | 220.80M | -129.60M | -20.00M | 404.00M | 216.60M |
| Pretax profit | 306.00M | 214.00M | -207.40M | -63.30M | 364.90M | 155.20M |
| Tax | 85.30M | 59.30M | -43.20M | -15.50M | 101.60M | 51.60M |
| Net profit | 217.50M | 149.10M | -151.90M | -125.00M | 238.60M | 112.20M |
| Basic EPS | 4 | 3 | -3 | -2 | 4 | 2 |
| Diluted EPS | 3.72 | 2.54 | -2.63 | -2.16 | 4.04 | 1.90 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 885.70M | 1.04B | 1.22B | 2.02B | 1.98B | 1.40B | 980.40M | 940.30M |
| Cash & ST investments | 33.90M | 18.80M | 16.60M | 244.10M | 86.80M | 31.90M | 71.60M | 36.60M |
| Inventory | 481.40M | 540.30M | 621.90M | 1.13B | 1.34B | 880.30M | 587.50M | 592.80M |
| Total assets | 3.05B | 3.03B | 3.38B | 4.80B | 4.30B | 3.41B | 2.87B | 2.74B |
| Total current liabilities | 612.70M | 620.50M | 950.40M | 1.14B | 963.90M | 773.70M | 750.30M | 739.70M |
| Short-term debt | 132.60M | 128.10M | 113.90M | 124.20M | 220.50M | 128.70M | 127.90M | 128.80M |
| Long-term debt | 1.88B | 1.52B | 1.46B | 2.24B | 2.83B | 2.56B | 2.17B | 2.05B |
| Total liabilities | 2,694,900,000.00 | 2,305,500,000.00 | 2,677,600,000.00 | 3,786,700,000.00 | 4,149,100,000.00 | 3,681,000,000.00 | 3,262,500,000.00 | 3,099,500,000.00 |
| Total equity | 359.60M | 723.20M | 702.90M | 1.01B | 147.70M | -267.30M | -390.60M | -357.50M |
| Retained earnings | 919.90M | 1.27B | 1.24B | 1.61B | 1.02B | 490.90M | 303.80M | 294.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.73B | 1.28B | 940.30M | 1.26B | 1.62B | 1.35B |
| Cash & ST investments | 16.90M | 51.10M | 36.60M | 8.30M | 6.20M | 27.70M |
| Inventory | 773.20M | 544.30M | 592.80M | 846.70M | 696.00M | 481.40M |
| Total assets | 3.54B | 3.09B | 2.74B | 3.03B | 3.41B | 3.17B |
| Total current liabilities | 1.01B | 798.60M | 739.70M | 932.40M | 1.28B | 1.11B |
| Short-term debt | 54.60M | 52.10M | 128.80M | 278.30M | 279.40M | 277.00M |
| Long-term debt | 2.49B | 2.14B | 2.05B | 2.25B | 2.07B | 1.84B |
| Total liabilities | 3,826,800,000.00 | 3,261,500,000.00 | 3,099,500,000.00 | 3,534,600,000.00 | 3,698,500,000.00 | 3,376,100,000.00 |
| Total equity | -290.10M | -170.90M | -357.50M | -500.60M | -286.50M | -208.70M |
| Retained earnings | 373.70M | 485.20M | 294.70M | 131.20M | 331.00M | 404.30M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 342.50M | 226.80M | 558.00M | 271.50M | -129.00M | 531.00M | 667.50M | 371.30M |
| Depreciation & amortization | 83.40M | 89.30M | 94.70M | 93.80M | 105.20M | 92.50M | 80.60M | 75.00M |
| Free cash flow | 274.30M | 184.40M | 495.30M | 164.60M | -242.50M | 438.20M | 583.50M | 273.90M |
| Dividends paid | -120.00M | -124.50M | -411.20M | -143.00M | -166.20M | -149.10M | -151.30M | -154.30M |
| Stock buybacks / issuance | -327.70M | -3.10M | -53.20M | -129.30M | -257.90M | -9.30M | -5.10M | -18.40M |
| Ending cash balance | 33.90M | 18.80M | 16.60M | 244.10M | 86.80M | 31.90M | 71.60M | 36.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 188.10M | 454.40M | 174.10M | -370.40M | 220.00M | 345.60M |
| Depreciation & amortization | 19.00M | 18.60M | 18.50M | 18.40M | 16.10M | 16.70M |
| Free cash flow | 179.80M | 437.50M | 131.20M | -390.40M | 201.40M | 321.10M |
| Dividends paid | -38.80M | -38.20M | -38.10M | -38.30M | -39.50M | -38.50M |
| Stock buybacks / issuance | -2.70M | -100.00K | 0 | -8.30M | -3.30M | -500.00K |
| Ending cash balance | 8.70M | 39.60M | 36.60M | 8.30M | 6.20M | 27.70M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.70 | 85.85 | 54.72 | 59.92 | -75.37 | -- | -- | -- |
| ROA %i | 2.20 | 15.15 | 12.09 | 12.53 | -9.62 | -9.86 | -1.11 | 5.17 |
| ROIC %i | 5.74 | 22.66 | 18.85 | 19.13 | -9.82 | -- | -- | -- |
| 5-year avg ROE %i | 29.09 | 40.99 | 46.50 | 49.04 | 27.56 | -- | -- | -- |
| EBIT margin %i | 7.59 | 21.65 | 14.29 | 15.35 | -11.21 | -7.75 | 3.81 | 10.27 |
| FCF / sales %i | 10.30 | 5.84 | 11.99 | 3.34 | -- | 12.34 | 16.42 | 8.03 |
| Current ratioi | 1.45 | 1.68 | 1.28 | 1.77 | 2.06 | 1.81 | 1.31 | 1.27 |
| Quick ratioi | 0.42 | 0.39 | 0.52 | 0.64 | 0.40 | 0.43 | 0.33 | 0.30 |
| Debt / assetsi | 66.01 | 54.53 | 49.76 | 54.07 | 76.10 | 85.13 | 87.67 | 86.81 |
| LT debt / equityi | 531.25 | 211.98 | 224.96 | 243.87 | 2,064.59 | -- | -- | -- |
| Interest coveragei | 2.34 | 6.71 | 7.41 | 9.58 | -3.73 | -1.55 | 0.85 | 2.72 |
| Revenue CAGR (3Y) %i | 3.95 | 7.99 | 16.07 | 22.74 | 7.53 | -4.92 | -10.32 | -4.54 |
| Net income CAGR (3Y) %i | -26.40 | 13.47 | 21.07 | 100.38 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -0.23 | 19.04 | -15.65 | -- | -4.00 | 52.48 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 0.97 | 1.61 | 5.17 | 2.89 | 3.19 | 2.36 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.31 | 6.84 | 10.27 | 10.92 | 12.25 | 10.41 |
| FCF / sales %i | 11.05 | 7.11 | 8.03 | 10.53 | 10.94 | 7.56 |
| Current ratioi | 1.71 | 1.61 | 1.27 | 1.35 | 1.27 | 1.21 |
| Quick ratioi | 0.81 | 0.78 | 0.30 | 0.22 | 0.61 | 0.67 |
| Debt / assetsi | 72.04 | 70.81 | 86.81 | 83.34 | 68.81 | 66.72 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 1.53 | 1.74 | 2.72 | 3.04 | 3.64 | 3.21 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- U.S. Consumer is the largest reported line at 88.12% of revenue, across 2 reported segments.
- The next-largest line, Other, is a distant second at 11.88% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
U.S. Consumer88.12%
Other11.88%
Quote time 2026-10-07 20:02:35 · For reference only, not investment advice and not tailored to your situation.